ArticlebioRxiv : the preprint server for biology2026
AR-V7 Utilizes a Noncanonical Nuclear Localization Signal to Sustain Androgen-Independent Nuclear Import and Signaling.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
AR-V7 is the most prevalent androgen receptor splice variant in metastatic castration-resistant prostate cancer, yet how it enters the nucleus independently of androgen binding has remained unclear. We previously demonstrated that AR-V7 undergoes nuclear import via a non-canonical pathway distinct from the microtubule-based, importin-α/β- and Ran-dependent mechanism used by full-length AR. Here, using systematic truncation and alanine-scanning mutagenesis, we identify a non-classical nuclear localization motif at the junction of the DNA-binding domain (DBD) and cryptic exon 3 (CE3) that is required for efficient AR-V7 nuclear import. Specific basic residues within the DBD and CE3 are required not only for nuclear entry but also for transcriptional activity. Unexpectedly, mutants retaining partial nuclear localization were transcriptionally silent, suggesting that CE3 contributes to transcriptional engagement through mechanisms separate from nuclear transport. Genome-wide transcriptomic analysis of a strongly import-deficient mutant confirmed that disruption of nuclear entry abolishes the AR-V7 transcriptional program. To map compartment-specific protein interactions, we applied antibody-guided photocatalytic proximity labeling. Nuclear AR-V7 associated most prominently with both canonical BAF and PBAF SWI/SNF chromatin remodeling complexes, together with known transcriptional coregulators and DNA-repair factors, whereas the cytoplasm-restricted mutant engaged different networks centered on mRNA deadenylation and decay, cytoskeletal regulation, and chaperone systems. Together, these findings define a variant-specific NLS, separate nuclear import from CE3-dependent transcriptional competence, and identify the cytoplasmic networks that become accessible when AR-V7 nuclear entry is impaired. They reveal two mechanistically distinct vulnerabilities for suppressing AR-V7 signaling: blocking nuclear translocation and disrupting CE3-dependent transcriptional engagement within the nucleus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.